Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jack Ball currently holds 15,706 shares of Cytek Biosciences, Inc. (CTKB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jack Ball has been a net seller of CTKB stock. They have purchased $51.0K and sold $235.0K worth of shares.
Jack Ball's most recent insider trade was on Jun 5, 2024, when they sold 15,706 shares at $0.00 per share.
Jack Ball serves as Executive at Cytek Biosciences, Inc. (CTKB). They have executed 7 insider transactions totaling $286.0K over their tenure at the company.
Jack Ball holds the position of Executive at Cytek Biosciences, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Jack Ball has shown a selling trading pattern, with $51.0K in total purchases and $235.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jack Ball was on Nov 14, 2022, when they sold $235.0K worth of CTKB shares. This transaction involved 16,000 shares at $14.69 per share.
Jack Ball currently owns 15,706 shares of Cytek Biosciences, Inc. (CTKB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jack Ball's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jack Ball has 7 Form 4 filings on record as an insider at Cytek Biosciences, Inc..
Set alerts for Jack Ball and 40,000+ other insiders.